Search Results - "Robledo, Mercedes"
-
1
MAX and MYC: A Heritable Breakup
Published in Cancer research (Chicago, Ill.) (01-07-2012)“…The overexpression of MYC, which occurs in many tumors, dramatically disrupts the equilibrium between activation and repression of the oncogenic…”
Get full text
Journal Article -
2
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension
Published in Journal of hypertension (01-08-2020)“…Phaeochromocytoma and paraganglioma (PPGL) are chromaffin cell tumours that require timely diagnosis because of their potentially serious cardiovascular and…”
Get full text
Journal Article -
3
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study
Published in The journal of clinical endocrinology and metabolism (01-06-2019)“…Abstract Background Malignant pheochromocytoma and paraganglioma (MPP) are characterized by prognostic heterogeneity. Our objective was to look for prognostic…”
Get full text
Journal Article -
4
Characteristics of Pediatric vs Adult Pheochromocytomas and Paragangliomas
Published in The journal of clinical endocrinology and metabolism (01-04-2017)“…Abstract Context: Pheochromocytomas and paragangliomas (PPGLs) in children are often hereditary and may present with different characteristics compared with…”
Get full text
Journal Article -
5
Life-cycle assessment of a photovoltaic system in Catalonia (Spain)
Published in Renewable & sustainable energy reviews (01-10-2011)“…The life-cycle analysis (LCA) of photovoltaic (PV) systems is an important tool to quantify the potential environmental advantage of using solar technologies…”
Get full text
Journal Article -
6
Association studies in thyroid cancer susceptibility: are we on the right track?
Published in Journal of molecular endocrinology (01-08-2011)“…It is widely accepted that thyroid cancer is strongly determined by the individual genetic background. In this regard, it is expected that sporadic thyroid…”
Get full text
Journal Article -
7
Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma
Published in The journal of clinical endocrinology and metabolism (01-10-2020)“…Abstract Context Pheochromocytomas and paragangliomas (PPGLs) are characterized by distinct genotype-phenotype relationships according to studies largely…”
Get full text
Journal Article -
8
MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma
Published in Clinical cancer research (15-05-2012)“…Pheochromocytomas (PCC) and paragangliomas (PGL) are genetically heterogeneous neural crest-derived neoplasms. Recently we identified germline mutations in a…”
Get full text
Journal Article -
9
Targeted Exome Sequencing of Krebs Cycle Genes Reveals Candidate Cancer-Predisposing Mutations in Pheochromocytomas and Paragangliomas
Published in Clinical cancer research (15-10-2017)“…Mutations in Krebs cycle genes are frequently found in patients with pheochromocytomas/paragangliomas. Disruption of SDH, FH or MDH2 enzymatic activities lead…”
Get full text
Journal Article -
10
Single nucleotide polymorphism associations with response and toxic effects in patients with advanced renal-cell carcinoma treated with first-line sunitinib: a multicentre, observational, prospective study
Published in The lancet oncology (01-11-2011)“…Summary Background Sunitinib is a tyrosine kinase inhibitor with proven efficacy in renal-cell carcinoma, but some patients do not respond or need dose…”
Get full text
Journal Article -
11
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
Published in Nature communications (28-02-2023)“…The mechanisms triggering metastasis in pheochromocytoma/paraganglioma are unknown, hindering therapeutic options for patients with metastatic tumors (mPPGL)…”
Get full text
Journal Article -
12
Cytoplasmic HIF-2α as tissue biomarker to identify metastatic sympathetic paraganglioma
Published in Scientific reports (18-07-2023)“…Pheochromocytomas (PCCs) and paragangliomas (PGLs) are rare neuroendocrine tumors. PGLs can further be divided into sympathetic (sPGLs) and head-and-neck…”
Get full text
Journal Article -
13
The miR-200 family controls β-tubulin III expression and is associated with paclitaxel-based treatment response and progression-free survival in ovarian cancer patients
Published in Endocrine-related cancer (01-02-2011)“…Ovarian cancer remains one of the leading causes of cancer deaths. Thus, new biomarkers predictive of response to the standard paclitaxel–carboplatin treatment…”
Get full text
Journal Article -
14
Hsa‐miR‐139‐5p is a prognostic thyroid cancer marker involved in HNRNPF‐mediated alternative splicing
Published in International journal of cancer (15-01-2020)“…It is critical to identify biomarkers and functional networks associated with aggressive thyroid cancer to anticipate disease progression and facilitate…”
Get full text
Journal Article -
15
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis
Published in Human molecular genetics (01-06-2013)“…Pheochromocytomas (PCCs) and paragangliomas (PGLs) are chromaffin-cell tumors that arise from the adrenal medulla and extra-adrenal paraganglia, respectively…”
Get full text
Journal Article -
16
Polymorphisms associated with everolimus pharmacokinetics, toxicity and survival in metastatic breast cancer
Published in PloS one (20-07-2017)“…Metastatic breast cancer (MBC) progressing after endocrine therapy frequently activates PI3K/AKT/mTOR pathway. The BOLERO-2 trial showed that…”
Get full text
Journal Article -
17
Role of MDH2 pathogenic variant in pheochromocytoma and paraganglioma patients
Published in Genetics in medicine (01-12-2018)“…MDH2 (malate dehydrogenase 2) has recently been proposed as a novel potential pheochromocytoma/paraganglioma (PPGL) susceptibility gene, but its role in the…”
Get full text
Journal Article -
18
REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial
Published in Molecular cancer (09-08-2023)“…Approximately 15% of adult GIST patients harbor tumors that are wild-type for KIT and PDGFRα genes (KP-wtGIST). These tumors usually have SDH deficiencies,…”
Get full text
Journal Article -
19
SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma
Published in The lancet oncology (01-04-2010)“…Summary Background Paragangliomas and phaeochromocytomas are neuroendocrine tumours associated frequently with germline mutations of SDHD, SDHC , and SDHB …”
Get full text
Journal Article -
20
DNA Methylation Profiling in Pheochromocytoma and Paraganglioma Reveals Diagnostic and Prognostic Markers
Published in Clinical cancer research (01-07-2015)“…Pheochromocytoma and paraganglioma (PPGL) are rare neuroendocrine tumors, associated with highly variable postoperative evolution. The scarcity of reliable…”
Get full text
Journal Article